Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Structural Neural Correlates of Cognitive Insight in Schizophrenia

FY 2014-15

Summary
Schizophrenia is distinct from other psychiatric illness by the fact that 50 to 80% of patients with schizophrenia are unaware of their condition. This phenomenon is called insight. Research has supported the association between poor insight and specific brain abnormalities. However, studies tend to use different approaches to study this relationship, and some neuroimaging techniques have been found to be less precise than others. For this study, I will be using Magnetic Resonance Imaging (MRI) to study cognitive insight, a subtype of insight that addresses distorted beliefs in patients. I hypothesize that poor insight will be related to cortical thinning in several regions in the frontal and temporal regions including the inferior and middle frontal gyri and the inferior temporal gyrus, key regions that have previously been shown to be associated with poor insight. Participants will be patients with schizophrenia that have been ill for at least five years. All assessments, including the brain scan, will be conducted at the Douglas Mental Health Institute (in Montreal, Canada). This project is part of a larger study on multiple dimensions of insight conducted by the Martin Lepage Laboratory. Hence, 113 participants have already been tested, and we expect to reach a sample size of 150 participants. It is important to invest in understanding the correlates of insight because poor insight has been associated with negative outcomes such as involuntary hospitalization, poor medical adherence and social functioning and cognitive deficits. In addition, no medication has yielded significant improvement in insight in patients with schizophrenia.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331386
Name
Azar Marleine
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Structural Neural Correlates of Cognitive Insight in Schizophrenia
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Insight; Magnetic Resonance Imaging (Mri); Schizophrenia; Structural Imaging
Abstract
Schizophrenia is distinct from other psychiatric illness by the fact that 50 to 80% of patients with schizophrenia are unaware of their condition. This phenomenon is called insight. Research has supported the association between poor insight and specific brain abnormalities. However, studies tend to use different approaches to study this relationship, and some neuroimaging techniques have been found to be less precise than others. For this study, I will be using Magnetic Resonance Imaging (MRI) to study cognitive insight, a subtype of insight that addresses distorted beliefs in patients. I hypothesize that poor insight will be related to cortical thinning in several regions in the frontal and temporal regions including the inferior and middle frontal gyri and the inferior temporal gyrus, key regions that have previously been shown to be associated with poor insight. Participants will be patients with schizophrenia that have been ill for at least five years. All assessments, including the brain scan, will be conducted at the Douglas Mental Health Institute (in Montreal, Canada). This project is part of a larger study on multiple dimensions of insight conducted by the Martin Lepage Laboratory. Hence, 113 participants have already been tested, and we expect to reach a sample size of 150 participants. It is important to invest in understanding the correlates of insight because poor insight has been associated with negative outcomes such as involuntary hospitalization, poor medical adherence and social functioning and cognitive deficits. In addition, no medication has yielded significant improvement in insight in patients with schizophrenia.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Azar, Marleine
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~